Ultrahigh-resolution mass spectrometers for heightened mAb characterization

This webinar highlights the needs and versatility of ultrahigh-resolution mass spectrometers for heightened mAb characterization in Pfizer’s MSBC lab, as well as addresses the importance of different separation techniques coupled to Mass Spectrometry. Following an introduction to Pfizer’s biotherapeutic heightened characterization strategy, discussions will be focused on in-depth understanding of biotherapeutics at the subunit level and hotspot characterization at the peptide level.

Run time: 31:48 mins

ultrahigh-resolution mass spectrometers for heightened mAb characterization

Video Credit: Bruker Life Sciences Mass Spectrometry

Other Videos by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.